Aurora Cannabis Inc (NYSE:ACB) fell 8.6% during mid-day trading on Wednesday . The company traded as low as $6.05 and last traded at $6.09, 13,694,566 shares were traded during trading. A decline of 35% from the average session volume of 21,088,656 shares. The stock had previously closed at $6.66.

A number of research firms recently issued reports on ACB. ValuEngine cut Aurora Cannabis from a “buy” rating to a “hold” rating in a research note on Friday, August 2nd. LADENBURG THALM/SH SH started coverage on Aurora Cannabis in a research note on Wednesday, July 17th. They set a “buy” rating and a $9.00 target price for the company. Bank of America downgraded Aurora Cannabis from a “buy” rating to a “neutral” rating and set a $7.30 price target for the company. in a research report on Thursday, July 18th. Compass Point started coverage on Aurora Cannabis in a research report on Monday, July 8th. They set a “neutral” rating for the company. Finally, Stifel Nicolaus started coverage on Aurora Cannabis in a research report on Wednesday, June 5th. They set a “hold” rating for the company. Six equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and an average target price of $8.23.

The company has a market capitalization of $6.65 billion, a P/E ratio of 51.00 and a beta of 2.44. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.98 and a current ratio of 2.37. The company’s fifty day moving average is $6.90.

Aurora Cannabis (NYSE:ACB) last released its quarterly earnings data on Tuesday, May 14th. The company reported ($0.08) EPS for the quarter, missing the consensus estimate of ($0.03) by ($0.05). The company had revenue of $49.00 million during the quarter, compared to analyst estimates of $50.92 million. Aurora Cannabis had a negative net margin of 122.65% and a positive return on equity of 1.24%. As a group, equities analysts expect that Aurora Cannabis Inc will post -0.23 earnings per share for the current fiscal year.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Deutsche Bank AG acquired a new stake in shares of Aurora Cannabis in the 4th quarter valued at approximately $3,105,000. Swiss National Bank boosted its holdings in shares of Aurora Cannabis by 5.9% in the 1st quarter. Swiss National Bank now owns 2,443,965 shares of the company’s stock valued at $22,117,000 after buying an additional 136,300 shares during the last quarter. Private Advisor Group LLC boosted its holdings in shares of Aurora Cannabis by 33.1% in the 1st quarter. Private Advisor Group LLC now owns 147,763 shares of the company’s stock valued at $1,339,000 after buying an additional 36,765 shares during the last quarter. North Star Investment Management Corp. lifted its holdings in Aurora Cannabis by 22.4% during the 2nd quarter. North Star Investment Management Corp. now owns 17,500 shares of the company’s stock valued at $137,000 after purchasing an additional 3,200 shares during the last quarter. Finally, CNB Bank lifted its holdings in Aurora Cannabis by 100.0% during the 1st quarter. CNB Bank now owns 4,000 shares of the company’s stock valued at $36,000 after purchasing an additional 2,000 shares during the last quarter. 9.10% of the stock is owned by institutional investors.

About Aurora Cannabis (NYSE:ACB)

Aurora Cannabis Inc produces and distributes medical cannabis products. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, from facility engineering and design to cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution.

Read More: Insider Trading – What You Need to Know

Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.